Evofem plans to carry out a reverse stock split at a ratio of not less than 5 to 1 and not more than 15 to 1. The decision is related to the threat of delisting the company's securities from the Nasdaq exchange. Evofem's August 2021 share price has fallen below $1, which does not meet the trading floor's requirements.